Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • TARGETED GENETICS CORP Financial Overview

  • Income Statement: TGEN

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 8.72 M 10.33 M -1.61 M -18.51%
    Gross Profit -6.46 M -7.38 M 912,000.00 -14.11%
    Net Income Before Extra Items/Preferred Div -20.72 M -16.13 M -4.59 M 22.17%
    Operating Income -12.29 M -14.41 M 2.12 M -17.25%
  • Cash Flow: TGEN

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -259,000.00 24.63 M -24.89 M 9,610.42%
    Net Cash Flow - Investing 662,000.00 514,000.00 148,000.00 22.36%
    Net Cash Flow/Operating Activities -10.30 M -13.88 M 3.58 M -34.71%
  • Balance Sheet: TGEN

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 7.15 M 28.47 M -21.32 M -298.24%
    Total Liabilities 10.92 M 12.23 M -1.31 M -12.01%
    Shareholders Equity -3.77 M 16.24 M -20.01 M 530.54%
  • Key Ratios / Statistics: TGEN

    • Valuation

      Price/Earnings (TTM) -0.21
      Price/Sales (TTM) 0.50
      Price/Book (MRQ) 3.34
      Price/Cash Flow (TTM) 7.93
    • Profitability

      Gross Margin -74.16
      Operating Margin -140.94
      Profit Margin -237.67
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 1.39
      Current Ratio (MRQ) 1.49
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -328.46
      Return on Assets (TTM) -70.20
      Return on Investments (TTM) -323.65